A simple blood test may one day detect ovarian cancer before it’s visible on a scan. This episode of Teal Talk–An Ovarian Cancer Podcast explores how liquid biopsy—a test that finds fragments of tumor DNA in the bloodstream—could change the future of diagnosis and treatment.

Listen as Dr. Hardesty, a member of NOCC’s Medical & Scientific Advisory Board, explains what makes liquid biopsy different from CA-125 or genetic testing, and why researchers are hopeful about its role in early detection.

📋 Take our quick listener survey: https://bit.ly/tealtalksurvey